nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

The phase 4 ABOUND.70+ trial assessed the safety and efficacy of nab-paclitaxel/carboplatin continuously or with a 1-week break between cycles in elderly patients with advanced non-small cell lung cancer (NSCLC). Patients ≥70 years with locally advanced/metastatic NSCLC were randomized 1:1 to first-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Langer, Corey J., Kim, Edward S., Anderson, Eric C., Jotte, Robert M., Modiano, Manuel, Haggstrom, Daniel E., Socoteanu, Matei P., Smith, David A., Dakhil, Christopher, Konduri, Kartik, Berry, Tymara, Ong, Teng J., Sanford, Alexandra, Amiri, Katayoun, Goldman, Jonathan W., Weiss, Jared
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066531/
https://ncbi.nlm.nih.gov/pubmed/30087851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00262
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars